세계의 동정맥루 디바이스 시장 규모, 점유율, 산업 동향 분석 리포트 : 최종 사용별, 유형별, 지역별 전망과 예측(2023-2030년)

The Global Arteriovenous Fistula Devices Market size is expected to reach $521.9 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period.

AVF procedures and equipment are in demand as a result of a considerable increase in renal disease cases in the Asia Pacific region. Therefore, the Asia Pacific region acquired $72.1 million revenue in the market in 2022. This development is explained by the rising incidence of ESRD and the number of people needing hemodialysis therapy. Additionally, the accessibility of these treatments has been facilitated by investments in cutting-edge medical technologies, such as AVF devices, and expanding healthcare infrastructure. Along with the existence of major market competitors and R&D efforts, the emphasis on improving patient outcomes as well as healthcare quality also contributes to the expansion of the market in this region. Some of the factors impacting the market are Increase in the demand for cutting-edge treatment techniques, growing prevalence of end-stage renal disease (ESRD), and numerous complications with AVF surgeries.

This market is anticipated to grow throughout the anticipated time frame as companies create novel treatment options such as antiangiogenic therapy, photodynamic therapy, and other sclerotherapy techniques. Players are motivated to develop cutting-edge treatment technologies since the ideal type of therapy for full recovery in a straightforward manner is still being developed. Early research findings are available, and minimally invasive novel system manufacturing techniques are being investigated. Additionally, many therapies in the research pipeline and upbeat government policies would increase demand for arteriovenous fistula devices throughout the projected period. Due to their long-term advantages as well as lower complication rates than alternative access methods, AVF devices are a favored vascular access option in response to the increased prevalence of chronic renal illnesses and ESRD. Each year, chronic kidney disease (CKD) causes thousands of people to pass away too soon and significantly lowers their quality of life. Hence, the increasing prevalence of ESRD will significantly augment the market's growth.

However, long surgical wait periods for the construction of AVFs and varied primary failure rates, which are AVFs that are never usable or fail within the initial three months, are two of the numerous obstacles to their usage. Between 20 and 70 percent of primary attempts fail. Needles are also necessary to reach the AV fistula for dialysis, which makes it an invasive procedure. Therefore, the market's growth would be constrained by the absence of successful therapies in treating the underlying causes of arteriovenous fistula.

COVID-19 Impact

The COVID-19 pandemic put a strain on the world's healthcare system. During the pandemic, a worldwide strategy to maintain the healthcare system was essential. Due to the severity of kidney disease, many governments allowed for its treatment even during the pandemic. However, the COVID-19 pandemic saw a rise in the number of dialysis-access thromboses as well as failed thrombectomies. This discrepancy was brought on by a delay in the patients' access maintenance operations. Therefore, the pandemic had a negative impact on the market.

End-Use Outlook

On the basis of end-use, the market is classified into hospitals, ambulatory surgical centers, and dialysis centers. The ambulatory surgical centers (ASCs) segment witnessed a considerable growth rate in the market in 2022. These facilities offer outpatient surgical services, like AVF procedures, which are more practical and affordable than hospitalization. ASCs have become a feasible option for carrying out these procedures because of the increase in demand for AVF production and monitoring. As they provide high-quality care at a lesser cost than hospitals, ASCs are in line with the move toward value-based healthcare as well as cost containment.

Type Outlook

Based on type, the market is characterized into AVF creation devices, AVF monitoring devices, and AVF maintenance devices. The AVF creation devices segment garnered the highest revenue share in the market in 2022. Greater demand for AVF procedures has been generated by the rising prevalence of ESRD as well as the rising number of people requiring dialysis treatment. By facilitating efficient vascular access, boosting patient care, and promoting quality of life, AVF creation devices are essential in supplying the growing need for dialysis treatment. The segment's expansion is being fueled by the introduction of cutting-edge products by major companies that speed up the AVF process.

AVF Creation Devices Type Outlook

The AVF creation devices segment is further subdivided into surgical instruments, vascular grafts, angioplasty balloons, and others. The surgical instruments segment acquired the largest revenue share in the market in 2022. Depending on the instrument's nature and functioning, an arteriovenous fistula surgical tool set may be built of German, Japanese, or local steel. Making a fully effective blood-transporting mechanism requires the use of the AV fistula surgical equipment set. Scalpels, tissue forceps, scissors, needle holders, self-retaining retractors, bulldog clamps, vessel loops, and any other preferred surgical clamps are needed during surgery.

AVF Monitoring Devices Type Outlook

The AVF monitoring devices segment is fragmented into doppler ultrasound, pressure monitoring systems, and others. The Doppler ultrasound segment witnessed the maximum revenue share in the market in 2022. When performing vessel mapping, Doppler ultrasound is used to assess the blood vessels that the surgeon might employ to create the AV fistula. An image of an organ's structure can be obtained with ultrasound by using a device called a transducer to bounce safe, harmless sound waves off of the organ. The process is carried out in a medical professional's office, an outpatient facility, or a hospital by a properly trained technician.

AVF Maintenance Devices Type Outlook

The AVF maintenance devices segment is classified into central venous catheters, stents, and others. The central venous catheters segment procured the highest revenue share in the market in 2022. While patients wait for an arteriovenous fistula to be placed and develop, central venous catheters (CVCs) are routinely utilized for hemodialysis (HD) vascular access. CVCs are now a crucial adjuvant in keeping patients on HD. The internal jugular as well as femoral veins are the best places to implant catheters, while the subclavian vein is regarded as the third option.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the maximum revenue share in the market in 2022. AVF devices are essential for supplying vascular access for hemodialysis, which is necessary given the high prevalence of kidney disease in North America. The expansion of the regional marketplace is attributed to the increasing demand for AVF treatments and the focus on patient outcomes. Furthermore, the market for arteriovenous fistula devices is expanding in North America due to the presence of significant manufacturers and advantageous healthcare regulations.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Becton, Dickinson and Company, Teleflex, Inc., Fresenius Medical Care AG & Co. KGaA. (Fresenius SE & Co. KGaA), B. Braun Melsungen AG, Poly Medicure Ltd., Asahi Kasei Corporation, Laminate Medical Technologies Ltd., Cook Medical, Inc. (Cook Group), and Boston Scientific Corporation

Scope of the Study

Market Segments covered in the Report:

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Dialysis Centers

By Type

• AVF Creation Devices
  • Surgical Instruments
  • Vascular Grafts
  • Angioplasty Balloons
  • Others
• AVF Monitoring Devices
  • Doppler Ultrasound
  • Pressure Monitoring Systems
  • Others
• AVF Maintenance Devices
  • Central Venous Catheters
  • Stents
  • Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Medtronic PLC
• Becton, Dickinson and Company
• Teleflex, Inc.
• Fresenius Medical Care AG & Co. KGaA. (Fresenius SE & Co. KGaA)
• B. Braun Melsungen AG
• Poly Medicure Ltd.
• Asahi Kasei Corporation
• Laminate Medical Technologies Ltd.
• Cook Medical, Inc. (Cook Group)
• Boston Scientific Corporation

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Arteriovenous Fistula Devices Market, by End-use
  • 1.4.2 Global Arteriovenous Fistula Devices Market, by Type
  • 1.4.3 Global Arteriovenous Fistula Devices Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Arteriovenous Fistula Devices Market by End-use

• 4.1 Global Hospitals Market by Region
• 4.2 Global Ambulatory Surgical Centers Market by Region
• 4.3 Global Dialysis Centers Market by Region

Chapter 5. Global Arteriovenous Fistula Devices Market by Type

• 5.1 Global AVF Creation Devices Market by Region
• 5.2 Global Arteriovenous Fistula Devices Market by AVF Creation Devices Type
  • 5.2.1 Global Surgical Instruments Market by Region
  • 5.2.2 Global Vascular Grafts Market by Region
  • 5.2.3 Global Angioplasty Balloons Market by Region
  • 5.2.4 Global Others Market by Region
• 5.3 Global AVF Monitoring Devices Market by Region
• 5.4 Global Arteriovenous Fistula Devices Market by AVF Monitoring Devices Type
  • 5.4.1 Global Doppler Ultrasound Market by Region
  • 5.4.2 Global Pressure Monitoring Systems Market by Region
  • 5.4.3 Global Others Market by Region
• 5.5 Global AVF Maintenance Devices Market by Region
• 5.6 Global Arteriovenous Fistula Devices Market by AVF Maintenance Devices Type
  • 5.6.1 Global Central Venous Catheters Market by Region
  • 5.6.2 Global Stents Market by Region
  • 5.6.3 Global Others Market by Region

Chapter 6. Global Arteriovenous Fistula Devices Market by Region

• 6.1 North America Arteriovenous Fistula Devices Market
  • 6.1.1 North America Arteriovenous Fistula Devices Market by End-use
    • 6.1.1.1 North America Hospitals Market by Country
    • 6.1.1.2 North America Ambulatory Surgical Centers Market by Country
    • 6.1.1.3 North America Dialysis Centers Market by Country
  • 6.1.2 North America Arteriovenous Fistula Devices Market by Type
    • 6.1.2.1 North America AVF Creation Devices Market by Country
    • 6.1.2.2 North America Arteriovenous Fistula Devices Market by AVF Creation Devices Type
      • 6.1.2.2.1 North America Surgical Instruments Market by Country
      • 6.1.2.2.2 North America Vascular Grafts Market by Country
      • 6.1.2.2.3 North America Angioplasty Balloons Market by Country
      • 6.1.2.2.4 North America Others Market by Country
    • 6.1.2.3 North America AVF Monitoring Devices Market by Country
    • 6.1.2.4 North America Arteriovenous Fistula Devices Market by AVF Monitoring Devices Type
      • 6.1.2.4.1 North America Doppler Ultrasound Market by Country
      • 6.1.2.4.2 North America Pressure Monitoring Systems Market by Country
      • 6.1.2.4.3 North America Others Market by Country
    • 6.1.2.5 North America AVF Maintenance Devices Market by Country
    • 6.1.2.6 North America Arteriovenous Fistula Devices Market by AVF Maintenance Devices Type
      • 6.1.2.6.1 North America Central Venous Catheters Market by Country
      • 6.1.2.6.2 North America Stents Market by Country
      • 6.1.2.6.3 North America Others Market by Country
  • 6.1.3 North America Arteriovenous Fistula Devices Market by Country
    • 6.1.3.1 US Arteriovenous Fistula Devices Market
      • 6.1.3.1.1 US Arteriovenous Fistula Devices Market by End-use
      • 6.1.3.1.2 US Arteriovenous Fistula Devices Market by Type
    • 6.1.3.2 Canada Arteriovenous Fistula Devices Market
      • 6.1.3.2.1 Canada Arteriovenous Fistula Devices Market by End-use
      • 6.1.3.2.2 Canada Arteriovenous Fistula Devices Market by Type
    • 6.1.3.3 Mexico Arteriovenous Fistula Devices Market
      • 6.1.3.3.1 Mexico Arteriovenous Fistula Devices Market by End-use
      • 6.1.3.3.2 Mexico Arteriovenous Fistula Devices Market by Type
    • 6.1.3.4 Rest of North America Arteriovenous Fistula Devices Market
      • 6.1.3.4.1 Rest of North America Arteriovenous Fistula Devices Market by End-use
      • 6.1.3.4.2 Rest of North America Arteriovenous Fistula Devices Market by Type
• 6.2 Europe Arteriovenous Fistula Devices Market
  • 6.2.1 Europe Arteriovenous Fistula Devices Market by End-use
    • 6.2.1.1 Europe Hospitals Market by Country
    • 6.2.1.2 Europe Ambulatory Surgical Centers Market by Country
    • 6.2.1.3 Europe Dialysis Centers Market by Country
  • 6.2.2 Europe Arteriovenous Fistula Devices Market by Type
    • 6.2.2.1 Europe AVF Creation Devices Market by Country
    • 6.2.2.2 Europe Arteriovenous Fistula Devices Market by AVF Creation Devices Type
      • 6.2.2.2.1 Europe Surgical Instruments Market by Country
      • 6.2.2.2.2 Europe Vascular Grafts Market by Country
      • 6.2.2.2.3 Europe Angioplasty Balloons Market by Country
      • 6.2.2.2.4 Europe Others Market by Country
    • 6.2.2.3 Europe AVF Monitoring Devices Market by Country
    • 6.2.2.4 Europe Arteriovenous Fistula Devices Market by AVF Monitoring Devices Type
      • 6.2.2.4.1 Europe Doppler Ultrasound Market by Country
      • 6.2.2.4.2 Europe Pressure Monitoring Systems Market by Country
      • 6.2.2.4.3 Europe Others Market by Country
    • 6.2.2.5 Europe AVF Maintenance Devices Market by Country
    • 6.2.2.6 Europe Arteriovenous Fistula Devices Market by AVF Maintenance Devices Type
      • 6.2.2.6.1 Europe Central Venous Catheters Market by Country
      • 6.2.2.6.2 Europe Stents Market by Country
      • 6.2.2.6.3 Europe Others Market by Country
  • 6.2.3 Europe Arteriovenous Fistula Devices Market by Country
    • 6.2.3.1 Germany Arteriovenous Fistula Devices Market
      • 6.2.3.1.1 Germany Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.1.2 Germany Arteriovenous Fistula Devices Market by Type
    • 6.2.3.2 UK Arteriovenous Fistula Devices Market
      • 6.2.3.2.1 UK Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.2.2 UK Arteriovenous Fistula Devices Market by Type
    • 6.2.3.3 France Arteriovenous Fistula Devices Market
      • 6.2.3.3.1 France Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.3.2 France Arteriovenous Fistula Devices Market by Type
    • 6.2.3.4 Russia Arteriovenous Fistula Devices Market
      • 6.2.3.4.1 Russia Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.4.2 Russia Arteriovenous Fistula Devices Market by Type
    • 6.2.3.5 Spain Arteriovenous Fistula Devices Market
      • 6.2.3.5.1 Spain Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.5.2 Spain Arteriovenous Fistula Devices Market by Type
    • 6.2.3.6 Italy Arteriovenous Fistula Devices Market
      • 6.2.3.6.1 Italy Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.6.2 Italy Arteriovenous Fistula Devices Market by Type
    • 6.2.3.7 Rest of Europe Arteriovenous Fistula Devices Market
      • 6.2.3.7.1 Rest of Europe Arteriovenous Fistula Devices Market by End-use
      • 6.2.3.7.2 Rest of Europe Arteriovenous Fistula Devices Market by Type
• 6.3 Asia Pacific Arteriovenous Fistula Devices Market
  • 6.3.1 Asia Pacific Arteriovenous Fistula Devices Market by End-use
    • 6.3.1.1 Asia Pacific Hospitals Market by Country
    • 6.3.1.2 Asia Pacific Ambulatory Surgical Centers Market by Country
    • 6.3.1.3 Asia Pacific Dialysis Centers Market by Country
  • 6.3.2 Asia Pacific Arteriovenous Fistula Devices Market by Type
    • 6.3.2.1 Asia Pacific AVF Creation Devices Market by Country
    • 6.3.2.2 Asia Pacific Arteriovenous Fistula Devices Market by AVF Creation Devices Type
      • 6.3.2.2.1 Asia Pacific Surgical Instruments Market by Country
      • 6.3.2.2.2 Asia Pacific Vascular Grafts Market by Country
      • 6.3.2.2.3 Asia Pacific Angioplasty Balloons Market by Country
      • 6.3.2.2.4 Asia Pacific Others Market by Country
    • 6.3.2.3 Asia Pacific AVF Monitoring Devices Market by Country
    • 6.3.2.4 Asia Pacific Arteriovenous Fistula Devices Market by AVF Monitoring Devices Type
      • 6.3.2.4.1 Asia Pacific Doppler Ultrasound Market by Country
      • 6.3.2.4.2 Asia Pacific Pressure Monitoring Systems Market by Country
      • 6.3.2.4.3 Asia Pacific Others Market by Country
    • 6.3.2.5 Asia Pacific AVF Maintenance Devices Market by Country
    • 6.3.2.6 Asia Pacific Arteriovenous Fistula Devices Market by AVF Maintenance Devices Type
      • 6.3.2.6.1 Asia Pacific Central Venous Catheters Market by Country
      • 6.3.2.6.2 Asia Pacific Stents Market by Country
      • 6.3.2.6.3 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Arteriovenous Fistula Devices Market by Country
    • 6.3.3.1 China Arteriovenous Fistula Devices Market
      • 6.3.3.1.1 China Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.1.2 China Arteriovenous Fistula Devices Market by Type
    • 6.3.3.2 Japan Arteriovenous Fistula Devices Market
      • 6.3.3.2.1 Japan Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.2.2 Japan Arteriovenous Fistula Devices Market by Type
    • 6.3.3.3 India Arteriovenous Fistula Devices Market
      • 6.3.3.3.1 India Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.3.2 India Arteriovenous Fistula Devices Market by Type
    • 6.3.3.4 South Korea Arteriovenous Fistula Devices Market
      • 6.3.3.4.1 South Korea Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.4.2 South Korea Arteriovenous Fistula Devices Market by Type
    • 6.3.3.5 Singapore Arteriovenous Fistula Devices Market
      • 6.3.3.5.1 Singapore Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.5.2 Singapore Arteriovenous Fistula Devices Market by Type
    • 6.3.3.6 Malaysia Arteriovenous Fistula Devices Market
      • 6.3.3.6.1 Malaysia Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.6.2 Malaysia Arteriovenous Fistula Devices Market by Type
    • 6.3.3.7 Rest of Asia Pacific Arteriovenous Fistula Devices Market
      • 6.3.3.7.1 Rest of Asia Pacific Arteriovenous Fistula Devices Market by End-use
      • 6.3.3.7.2 Rest of Asia Pacific Arteriovenous Fistula Devices Market by Type
• 6.4 LAMEA Arteriovenous Fistula Devices Market
  • 6.4.1 LAMEA Arteriovenous Fistula Devices Market by End-use
    • 6.4.1.1 LAMEA Hospitals Market by Country
    • 6.4.1.2 LAMEA Ambulatory Surgical Centers Market by Country
    • 6.4.1.3 LAMEA Dialysis Centers Market by Country
  • 6.4.2 LAMEA Arteriovenous Fistula Devices Market by Type
    • 6.4.2.1 LAMEA AVF Creation Devices Market by Country
    • 6.4.2.2 LAMEA Arteriovenous Fistula Devices Market by AVF Creation Devices Type
      • 6.4.2.2.1 LAMEA Surgical Instruments Market by Country
      • 6.4.2.2.2 LAMEA Vascular Grafts Market by Country
      • 6.4.2.2.3 LAMEA Angioplasty Balloons Market by Country
      • 6.4.2.2.4 LAMEA Others Market by Country
    • 6.4.2.3 LAMEA AVF Monitoring Devices Market by Country
    • 6.4.2.4 LAMEA Arteriovenous Fistula Devices Market by AVF Monitoring Devices Type
      • 6.4.2.4.1 LAMEA Doppler Ultrasound Market by Country
      • 6.4.2.4.2 LAMEA Pressure Monitoring Systems Market by Country
      • 6.4.2.4.3 LAMEA Others Market by Country
    • 6.4.2.5 LAMEA AVF Maintenance Devices Market by Country
    • 6.4.2.6 LAMEA Arteriovenous Fistula Devices Market by AVF Maintenance Devices Type
      • 6.4.2.6.1 LAMEA Central Venous Catheters Market by Country
      • 6.4.2.6.2 LAMEA Stents Market by Country
      • 6.4.2.6.3 LAMEA Others Market by Country
  • 6.4.3 LAMEA Arteriovenous Fistula Devices Market by Country
    • 6.4.3.1 Brazil Arteriovenous Fistula Devices Market
      • 6.4.3.1.1 Brazil Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.1.2 Brazil Arteriovenous Fistula Devices Market by Type
    • 6.4.3.2 Argentina Arteriovenous Fistula Devices Market
      • 6.4.3.2.1 Argentina Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.2.2 Argentina Arteriovenous Fistula Devices Market by Type
    • 6.4.3.3 UAE Arteriovenous Fistula Devices Market
      • 6.4.3.3.1 UAE Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.3.2 UAE Arteriovenous Fistula Devices Market by Type
    • 6.4.3.4 Saudi Arabia Arteriovenous Fistula Devices Market
      • 6.4.3.4.1 Saudi Arabia Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.4.2 Saudi Arabia Arteriovenous Fistula Devices Market by Type
    • 6.4.3.5 South Africa Arteriovenous Fistula Devices Market
      • 6.4.3.5.1 South Africa Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.5.2 South Africa Arteriovenous Fistula Devices Market by Type
    • 6.4.3.6 Nigeria Arteriovenous Fistula Devices Market
      • 6.4.3.6.1 Nigeria Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.6.2 Nigeria Arteriovenous Fistula Devices Market by Type
    • 6.4.3.7 Rest of LAMEA Arteriovenous Fistula Devices Market
      • 6.4.3.7.1 Rest of LAMEA Arteriovenous Fistula Devices Market by End-use
      • 6.4.3.7.2 Rest of LAMEA Arteriovenous Fistula Devices Market by Type

Chapter 7. Company Profiles

• 7.1 Medtronic PLC
  • 7.1.1 Company overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expenses
  • 7.1.5 Recent strategies and developments:
    • 7.1.5.1 Trials and Approvals:
    • 7.1.5.2 Acquisition and Mergers:
  • 7.1.6 SWOT Analysis
• 7.2 Teleflex, Inc.
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental Analysis
  • 7.2.4 Research & Development Expense
  • 7.2.5 SWOT Analysis
• 7.3 Fresenius Medical Care AG & Co. KGaA (Fresenius SE & Co. KGaA)
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental and Regional Analysis
  • 7.3.4 Research & Development Expenses
  • 7.3.5 SWOT Analysis
• 7.4 Asahi Kasei Corporation
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental and Regional Analysis
  • 7.4.4 Research & Development Expenses
• 7.5 Becton, Dickinson, and Company
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Segmental and Regional Analysis
  • 7.5.4 Research & Development Expense
  • 7.5.5 SWOT Analysis
• 7.6 B. Braun Melsungen AG
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expenses
  • 7.6.5 SWOT Analysis
• 7.7 Poly Medicure Ltd.
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Regional Analysis
  • 7.7.4 Research & Development Expenses
  • 7.7.5 SWOT Analysis
• 7.8 Cook Medical, Inc. (Cook Group)
  • 7.8.1 Company Overview
  • 7.8.2 SWOT Analysis
• 7.9 Boston Scientific Corporation
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental and Regional Analysis
  • 7.9.4 Research & Development Expense
  • 7.9.5 SWOT Analysis
• 7.10. Laminate Medical Technologies Ltd.
  • 7.10.1 Company Overview
  • 7.10.2 SWOT Analysis

Chapter 8. Winning Imperative for Arteriovenous Fistula Devices Market